Bradway Robert A 4
4 · AMGEN INC · Filed May 7, 2024
Insider Transaction Report
Form 4
AMGEN INCAMGN
Bradway Robert A
Executive V.P. and CFO
Transactions
- Tax Payment
Common Stock
2024-05-05$311.29/sh−2,220$691,064→ 657,281 total
Footnotes (2)
- [F1]These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 4,516 RSUs which will vest on 4/30/2025; 9,234 RSUs which will vest in installments of 4,548 on 5/2/2025, and 4,686 on 5/2/2026; and 13,486 RSUs which will vest in two installments of 4,450 each on 5/2/2025 and 5/2/2026, and one installment of 4,586 on 5/2/2027. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- [F2]These shares include 1,555 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.